Bringing the fundamentals into focus…
Back to Avalyn Pharma Inc.
How Avalyn Pharma Inc. stacks up
AVLN · against 467 other Healthcare companies of similar size
Valuation
0/ 100
Near the bottom of its peers.
Ranked #431 of 468 · scores higher than 0% of peers
Bars: peers in each 10-point band of the valuation score140 peers with a valuation score of 0–9, including AVLN · Click a bar to see the companies
Why valuation scores 0?
Weighted metrics compared with all Healthcare companies.Mainly because of its EBITDA yield and earnings yield, which are weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -12.9% vs peer median 4.0%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -8.7% vs peer median 1.5%
- Free cash flow yield is not reported, so it is left out of the score.
Metric by metric
Position: dot = AVLN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | AVLN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 459 reported | -8.7% | 1.5% | 20% | 30% | |
| EBITDA yieldHigher is better · 471 reported | -12.9% | 4.3% | 13% | 50% | |
| Free cash flow yieldHigher is better · 206 reported | Not reported | -1.6% | — | — | 20% |
| Book yieldHigher is better · 463 reported | 33.5% | 40.7% | 41% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by valuation score
Top 5 and the companies ranked around AVLN| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 12.9B HKD (≈$1.7B) | 99 | 83 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 40.2B MXN (≈$2.2B) | 99 | 71 | |
| 431 | 7.2B CNY (≈$1.0B) | 0 | 34 | |
| 431 | 14.2B CNY (≈$2.0B) | 0 | 10 | |
| 431 | 1.0B USD | 0 | 35 | |
| 431 | 617M USD | 0 | 28 | |
| 431 | 1.2B USD | 0 | ||
| 431 | 1.2B USD | 0 | 3 | |
| 431 | 1.8B USD | 0 | 30 | |
| 431 | 555M EUR (≈$611M) | 0 | 25 | |
| 431 | 1.2B CHF (≈$1.3B) | 0 | 28 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score